NRL is a California based innovative Biotechnology and Pharmaceutical Company based in San Francisco Bay Area. Founded in 2008 with executives of over 25 years of solid experience in Biotechnology and Pharmaceutical drug discovery industries, NRL operates all its business activities through four major divisions:

		BioTechnology R&D							Drug-Discovery
		Developing propreitary and patented novel kits & reagents							New class of drugs using NRL platform technologies
			Electrophoresis							NPCC Technology
			Protein Biochemsitry							Epitope based Antibodies
			Molecular Biology							GPCRs Modulation
			Immunology